Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Pain 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Cancer Pain 1

Interventions

Dexamethasone 139Lenalidomide 75Cyclophosphamide 73Bortezomib 73Calcium Dobesilate 57fludarabine 49pomalidomide 43daratumumab 39fludarabine phosphate 34carfilzomib 33Melphalan 29dexamethasone acetate 24dexamethasone 21-phosphate 24auricularum 22Filgrastim 18Whole-Body Irradiation 15Biopsy 14ixazomib 13isatuximab 13Magnetic Resonance Spectroscopy 13Granulocyte Colony-Stimulating Factor 13Vorinostat 12Tacrolimus 12Specimen Handling 12Sirolimus 12Peripheral Blood Stem Cell Transplantation 12venetoclax 11belantamab mafodotin 11Rituximab 11Panobinostat 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sodium Bicarbonate × Plasma cell × Clear all
NCT01846429 2015-06-04

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cancer Pain, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡